Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial

Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulse...

Descripción completa

Detalles Bibliográficos
Autores principales: Solanich, Xavier, Antolí, Arnau, Rocamora-Blanch, Gemma, Padullés, Núria, Fanlo-Maresma, Marta, Iriarte, Adriana, Mitjavila, Francesca, Capdevila, Olga, Riera-Mestre, Antoni, Bas, Jordi, Vicens-Zygmunt, Vanesa, Niubó, Jordi, Calvo, Nahum, Bolivar, Santiago, Rigo-Bonnin, Raúl, Mensa-Vilaró, Anna, Arregui, Laura, Tebe, Cristian, Videla, Sebastià, Hereu, Pilar, Corbella, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236585/
https://www.ncbi.nlm.nih.gov/pubmed/34195214
http://dx.doi.org/10.3389/fmed.2021.691712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236585/
https://www.ncbi.nlm.nih.gov/pubmed/34195214
http://dx.doi.org/10.3389/fmed.2021.691712

Ejemplares similares